Liver transplantation for hepatocellular carcinoma: an Asian perspective.
Liver transplantation is an established treatment modality for patients with hepatocellular carcinoma (HCC), creating a potential for disease-free, long-term survival. In Asia, due to a severe shortage of donors, resection remains the treatment of choice for patients with HCC and good liver functional reserve. The use of marginal donors, split liver grafts and grafts from living donors are potential solutions that are best performed in experienced liver transplant centres to ensure an optimal outcome. Ethical issues relating to living donor liver transplantation have yet to be fully addressed. The roles of therapies to limit tumour progression during the waiting period, such as transarterial chemoembolization, need to be further investigated in the setting of a prospective trial and their benefits better defined.
Mak
Kenneth S W
KS
Liver Transplant Unit, National University Hospital, Singapore. kennethmak@medscape.com
Tan
Kai Chah
KC
D001208:Asia / Q000453:epidemiology; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000706:statistics & numerical data; D019520:Living Donors; D011379:Prognosis; D009927:Tissue and Organ Procurement